Katy Malpass

614 total citations
43 papers, 498 citations indexed

About

Katy Malpass is a scholar working on Molecular Biology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Katy Malpass has authored 43 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Neurology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Katy Malpass's work include Multiple Sclerosis Research Studies (7 papers), Alzheimer's disease research and treatments (6 papers) and Mitochondrial Function and Pathology (5 papers). Katy Malpass is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Alzheimer's disease research and treatments (6 papers) and Mitochondrial Function and Pathology (5 papers). Katy Malpass collaborates with scholars based in United Kingdom. Katy Malpass's co-authors include Stephen M. Anderton, Leigh A. Stephens, Richard A. O’Connor, Kenneth J. Smith, David A. Bechtold, Arthur Roach, Thomas M. Piers, Daniel M. Snell, Woojin Lee and Jennifer M. Pocock and has published in prestigious journals such as The Journal of Immunology, Brain and European Journal of Immunology.

In The Last Decade

Katy Malpass

42 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katy Malpass United Kingdom	8	267	99	88	82	79	43	498
Tina Leuenberger Germany	10	254 1.0×	122 1.2×	188 2.1×	63 0.8×	133 1.7×	11	556
Sarah B. Simmons United States	5	219 0.8×	84 0.8×	126 1.4×	55 0.7×	126 1.6×	6	377
Jane M. Rodgers United States	6	193 0.7×	113 1.1×	178 2.0×	44 0.5×	129 1.6×	8	428
René Gollan Germany	10	164 0.6×	103 1.0×	208 2.4×	78 1.0×	48 0.6×	13	412
Neda Haghayegh Jahromi Switzerland	11	148 0.6×	119 1.2×	181 2.1×	55 0.7×	46 0.6×	17	450
Sarrabeth Stone United States	15	143 0.5×	209 2.1×	103 1.2×	61 0.7×	97 1.2×	20	561
Beatriz Valle‐Argos United Kingdom	11	115 0.4×	151 1.5×	127 1.4×	52 0.6×	48 0.6×	20	434
Patrick Cullen United States	12	183 0.7×	301 3.0×	118 1.3×	56 0.7×	72 0.9×	16	602
Melinda Czéh Germany	5	149 0.6×	84 0.8×	161 1.8×	96 1.2×	23 0.3×	6	401
Jillian C. Nissen United States	12	180 0.7×	139 1.4×	277 3.1×	45 0.5×	74 0.9×	16	497

Countries citing papers authored by Katy Malpass

Since Specialization

Citations

This map shows the geographic impact of Katy Malpass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Malpass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Malpass more than expected).

Fields of papers citing papers by Katy Malpass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katy Malpass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Malpass. The network helps show where Katy Malpass may publish in the future.

Co-authorship network of co-authors of Katy Malpass

This figure shows the co-authorship network connecting the top 25 collaborators of Katy Malpass. A scholar is included among the top collaborators of Katy Malpass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katy Malpass. Katy Malpass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bechtold, David A., Woojin Lee, Daniel M. Snell, et al.. (2013). Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. Brain. 136(4). 1067–1082. 65 indexed citations

Malpass, Katy. (2013). Advancing our understanding of dystonias—genetic studies reveal TUBB4 mutation in patients with dystonia type 4. Nature Reviews Neurology. 9(2). 59–59. 2 indexed citations

Malpass, Katy. (2013). Fibroblast-derived OPCs—hope for remyelination therapy?. Nature Reviews Neurology. 9(6). 299–299. 1 indexed citations

Malpass, Katy. (2013). Discovery of DEPDC5 mutations provides further evidence of a genetic link to inherited focal epilepsies. Nature Reviews Neurology. 9(5). 237–237. 2 indexed citations

Malpass, Katy. (2013). Plaque-specific anti-Aβ antibody shows promise in model of AD. Nature Reviews Neurology. 9(2). 61–61. 4 indexed citations

Malpass, Katy. (2013). Read all about it! Why TBI is big news. Nature Reviews Neurology. 9(4). 179–179. 5 indexed citations

Malpass, Katy. (2012). Unsilencing dormant Ube3a—hope for Angelman syndrome?. Nature Reviews Neurology. 8(2). 62–62. 2 indexed citations

Malpass, Katy. (2012). Unlocking the secrets of autism through whole-exome sequencing. Nature Reviews Neurology. 8(6). 295–295. 3 indexed citations

Malpass, Katy. (2012). B vitamins show benefit in absence of antiplatelet therapy. Nature Reviews Neurology. 8(6). 298–298. 1 indexed citations

10.

Malpass, Katy. (2012). MicroRNAs in CSF—biomarkers of brain cancers and disease activity. Nature Reviews Neurology. 8(6). 297–297. 1 indexed citations

11.

Malpass, Katy. (2012). A novel imaging method to quantify low levels of dystrophin in Duchenne muscular dystrophy. Nature Reviews Neurology. 8(3). 120–120. 2 indexed citations

12.

Malpass, Katy. (2012). DNA damage provides novel and powerful biomarkers of Alzheimer disease. Nature Reviews Neurology. 8(4). 178–178. 1 indexed citations

13.

Malpass, Katy. (2012). Shining a light on seizure control—optogenetic approach shows promise for treatment and prevention of epilepsies. Nature Reviews Neurology. 9(1). 1–1. 3 indexed citations

14.

Malpass, Katy. (2011). Exercise is effective as a nonpharmacological approach to reduce the frequency of migraines. Nature Reviews Neurology. 7(11). 596–596. 1 indexed citations

15.

Malpass, Katy. (2011). New methods to permeabilize the blood–brain barrier. Nature Reviews Neurology. 7(11). 597–597. 4 indexed citations

16.

Malpass, Katy. (2011). The kynurenine pathway—promising new targets and therapies for neurodegenerative disease. Nature Reviews Neurology. 7(8). 417–417. 7 indexed citations

17.

Malpass, Katy. (2011). Functional networks are altered in mild cognitive impairment. Nature Reviews Neurology. 7(7). 356–356. 3 indexed citations

18.

Malpass, Katy. (2011). Functional screening identifies novel candidate risk genes in amyotrophic lateral sclerosis. Nature Reviews Neurology. 8(1). 1–1. 1 indexed citations

19.

Malpass, Katy. (2011). HLA-DRB1 genotypes linked to the risk of developing neutralizing antibodies to recombinant IFN-β during therapy. Nature Reviews Neurology. 7(6). 304–304. 1 indexed citations

20.

Stephens, Leigh A., Katy Malpass, & Stephen M. Anderton. (2009). Curing CNS autoimmune disease with myelin‐reactive Foxp3⁺ Treg. European Journal of Immunology. 39(4). 1108–1117. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact